T. Rowe Price Associates’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
350,259
+197,759
| +130% | +$552K | ﹤0.01% | 1997 |
|
|
2025
Q1 | $548K | Buy |
+152,500
| New | +$548K | ﹤0.01% | 2215 |
|
|
2023
Q2 | – | Sell |
-69,854
| Closed | -$60K | – | 2896 |
|
|
2023
Q1 | $60K | Sell |
69,854
-153,349
| -69% | -$132K | ﹤0.01% | 2767 |
|
|
2022
Q4 | $207K | Buy |
223,203
+5,269
| +2% | +$4.89K | ﹤0.01% | 2516 |
|
|
2022
Q3 | $371K | Buy |
217,934
+81,834
| +60% | +$139K | ﹤0.01% | 2273 |
|
|
2022
Q2 | $291K | Buy |
136,100
+57,605
| +73% | +$123K | ﹤0.01% | 2446 |
|
|
2022
Q1 | $279K | Buy |
78,495
+32,178
| +69% | +$114K | ﹤0.01% | 2570 |
|
|
2021
Q4 | $172K | Buy |
46,317
+21,745
| +88% | +$80.8K | ﹤0.01% | 2787 |
|
|
2021
Q3 | $182K | Buy |
+24,572
| New | +$182K | ﹤0.01% | 2741 |
|